Supervised Exercise for Opioid Use Disorder
(HELM Trial)
Trial Summary
What is the purpose of this trial?
This study aims to examine the effectiveness of a supervised aerobic exercise program for persons with Opioid Use Disorder (OUD). Participants will be enrolled in a 12-week supervised aerobic exercise intervention.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since participants must be on opioid maintenance treatment or have mild opioid use disorder, it seems likely that you can continue your current medications.
What data supports the effectiveness of the supervised exercise treatment for opioid use disorder?
Research suggests that exercise can be a helpful addition to treatment for opioid use disorder, as it may improve mood, reduce cravings, and enhance overall quality of life. Studies have shown that exercise can lead to positive outcomes like better mental health and reduced anxiety and depression in individuals with substance use disorders.12345
Is supervised exercise safe for people with opioid use disorder?
Research suggests that supervised exercise is generally safe for individuals with opioid use disorder, as it has been shown to improve mood, reduce cravings, and enhance quality of life without significant safety concerns. However, adherence to the exercise program is important to fully benefit from its physical and mental health advantages.12678
How is the Supervised Exercise Intervention treatment different from other treatments for opioid use disorder?
Research Team
Meredith S Berry, PhD
Principal Investigator
University of Florida
Eligibility Criteria
This trial is for adults aged 21-64 with mild to severe Opioid Use Disorder, who are not very active physically and can visit the research center weekly for 12 weeks. They must be able to exercise safely as determined by a medical exam. Pregnant individuals, those in other exercise or weight loss programs, or with certain medical conditions like heart disease or uncontrolled diabetes cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessment before starting the intervention
Treatment
Participants engage in a 12-week supervised aerobic exercise program, completing 3 walking sessions per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Supervised Exercise Intervention
Supervised Exercise Intervention is already approved in United States, European Union, Canada for the following indications:
- Peripheral Artery Disease
- Symptomatic Peripheral Artery Disease
- Opioid Use Disorder (as part of comprehensive treatment)
- Peripheral Arterial Disease
- Cardiovascular Rehabilitation
- Chronic Conditions Management
- Cardiovascular Health
- Chronic Disease Management
- Mental Health Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor